LRI Investments LLC Sells 711 Shares of Encompass Health Corporation (NYSE:EHC)

LRI Investments LLC lessened its position in shares of Encompass Health Corporation (NYSE:EHCFree Report) by 46.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 832 shares of the company’s stock after selling 711 shares during the quarter. LRI Investments LLC’s holdings in Encompass Health were worth $84,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Louisiana State Employees Retirement System raised its position in Encompass Health by 0.7% during the first quarter. Louisiana State Employees Retirement System now owns 28,200 shares of the company’s stock worth $2,856,000 after acquiring an additional 200 shares during the period. Xponance Inc. lifted its position in shares of Encompass Health by 1.6% during the first quarter. Xponance Inc. now owns 11,604 shares of the company’s stock worth $1,175,000 after purchasing an additional 187 shares in the last quarter. State of Michigan Retirement System lifted its position in shares of Encompass Health by 1.3% during the first quarter. State of Michigan Retirement System now owns 24,145 shares of the company’s stock worth $2,445,000 after purchasing an additional 300 shares in the last quarter. Alps Advisors Inc. raised its holdings in Encompass Health by 9.8% in the first quarter. Alps Advisors Inc. now owns 200,462 shares of the company’s stock valued at $20,303,000 after acquiring an additional 17,832 shares in the last quarter. Finally, TD Private Client Wealth LLC raised its holdings in Encompass Health by 23.3% in the first quarter. TD Private Client Wealth LLC now owns 3,065 shares of the company’s stock valued at $310,000 after acquiring an additional 580 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling at Encompass Health

In other news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the transaction, the executive vice president directly owned 79,710 shares in the company, valued at approximately $9,149,910.90. This represents a 11.15% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of the firm’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the transaction, the chief executive officer directly owned 527,070 shares of the company’s stock, valued at approximately $64,054,817.10. This represents a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 132,663 shares of company stock valued at $16,034,082. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Trading Up 1.0%

Shares of EHC opened at $119.64 on Tuesday. The company has a market cap of $12.06 billion, a price-to-earnings ratio of 24.72, a PEG ratio of 2.41 and a beta of 0.88. Encompass Health Corporation has a 52-week low of $82.74 and a 52-week high of $123.13. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a fifty day moving average price of $119.65 and a two-hundred day moving average price of $106.55.

Encompass Health (NYSE:EHCGet Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The company’s revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.12 earnings per share. Analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health’s dividend payout ratio is currently 14.05%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on EHC shares. Wall Street Zen lowered shares of Encompass Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 6th. Truist Financial reiterated a “buy” rating and set a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. UBS Group lifted their price objective on Encompass Health from $117.00 to $130.00 and gave the stock a “buy” rating in a research report on Monday, April 28th. Barclays boosted their target price on Encompass Health from $118.00 to $129.00 and gave the stock an “overweight” rating in a report on Friday, April 25th. Finally, Stephens raised Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and a consensus price target of $131.50.

Check Out Our Latest Stock Report on Encompass Health

About Encompass Health

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Featured Articles

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHCFree Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.